11.97
Caredx Inc 주식(CDNA)의 최신 뉴스
CareDx Reports Strong Growth in Testing Services - MSN
CareDx, Inc (NASDAQ:CDNA) Q2 2025 Earnings Call Transcript - Insider Monkey
CareDx Q2 2025 slides: 14% revenue growth despite analyst miss, EBITDA surges - Investing.com
CareDx Publishes KOAR Study In American Journal of Transplantation, Showcasing AlloSure Dd-cfDNA For Enhanced Kidney Rejection Detection And Biopsy Guidance - 富途牛牛
CareDx Inc. Reports Strong Growth Amid Challenges - TipRanks
CareDx secretary Novack sells $34,380 in shares - Investing.com
CareDx secretary Novack sells $34,380 in shares By Investing.com - Investing.com Canada
CareDx Appoints New CFO Amid Financial Growth - MSN
CareDx Faces Financial Challenges Amid Mixed Signals and Policy Uncertainties - TipRanks
CareDx 2025 Q2 Earnings EPS Beats Expectations, Net Loss Widens - AInvest
CareDx narrows 2025 revenue guidance to $367M-$373M as kidney surveillance protocols expand - MSN
CareDx Names Nathan Smith as Chief Financial Officer - MarketScreener
CareDx (CDNA) EPS Beats Sales Gain 14% - sharewise.com
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts By Investing.com - Investing.com South Africa
Earnings call transcript: CareDx Q2 2025 misses revenue forecasts - Investing.com
CareDx Publishes Landmark KOAR Study on AlloSure Efficacy in Kidney Transplant Surveillance in American Journal of Transplantation. - AInvest
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - BioSpace
CareDx Names Nathan Smith as New CFO - AInvest
Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings - Yahoo Finance
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates - Nasdaq
CareDx: Q2 Earnings Snapshot - San Antonio Express-News
CareDx Inc. Faces Q2 Loss with Revenue Below ExpectationsNews and Statistics - IndexBox
CareDx's Strategic Leadership Shift: How CFO Nathan Smith's Appointment Signals a New Era of Growth - AInvest
Caredx Inc earnings beat by $0.20, revenue fell short of estimates - Investing.com South Africa
CareDx narrows FY25 revenue view to $367M-$373M from $365M-$375M - TipRanks
CareDx Q2 Testing Volume Surges 20%, Narrows 2025 Revenue Outlook | CDNA Stock News - Stock Titan
CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation - Lelezard
AlloSure kidney transplant test shows strong predictive value for rejection By Investing.com - Investing.com Nigeria
Pinnacle West Q2 Earnings In Line With Estimates, Revenues Rise Y/Y - The Globe and Mail
CareDx ($CDNA) Is Paying a $20.25M Settlement to Investors — Here’s How to Get Your Share - TradingView
What are the technical indicators suggesting about CareDx IncFree Stock Market Return Analysis - Jammu Links News
What are the latest earnings results for CareDx IncGet alerts on high-potential stock breakouts - Jammu Links News
When is CareDx Inc stock expected to show significant growthStrong return on investment - Jammu Links News
Does CareDx Inc stock perform well during market downturnsDiscover dynamic stocks ready to soar - Jammu Links News
How does CareDx Inc compare to its industry peersAchieve consistent profits with disciplined trading - Jammu Links News
Is CareDx Inc stock overvalued or undervaluedExceptional portfolio growth - Jammu Links News
Should I hold or sell CareDx Inc stock in 2025Invest smarter with advanced market data - Jammu Links News
Why is CareDx Inc stock attracting strong analyst attentionStrongest growth potential - Jammu Links News
How volatile is CareDx Inc stock compared to the marketMaximize your returns with expert insights - Jammu Links News
What analysts say about CareDx Inc stockMaximize gains with data-driven trading alerts - Jammu Links News
What is the dividend policy of CareDx Inc stockFree Stock Market Return Analysis - Jammu Links News
What institutional investors are buying CareDx Inc stockTremendous financial leverage - Jammu Links News
Is CareDx Inc a growth stock or a value stockAchieve rapid financial growth with expert picks - Jammu Links News
No Bull | The Five Spot - The Globe and Mail
CareDx’s ALAMO Study: Advancing Lung Transplant Surveillance - TipRanks
CareDx’s HeartCare Study: A Game Changer in Heart Transplant Monitoring? - TipRanks
CareDx launches AI-driven AlloSure Plus integrated with EPIC Aura - Investing.com Australia
자본화:
|
볼륨(24시간):